Vicki Moore, PhD

Tisotumab vedotin proved more effective than chemotherapy for patients with recurrent or metastatic cervical cancer in a phase 3 trial.

Breast cancer patients with obesity may derive less of a benefit from aromatase inhibitors than patients of a “healthy” weight, according to researchers.

A study evaluated physician and staff perceptions of the significance of data collection on sexual orientation and gender identity in community oncology practices.

A recent study described approaches used globally for treating urinary incontinence after radical cystectomy and orthotopic neobladder reconstruction.

Certain aspects of oral health associated with overall survival in a study of patients with head and neck squamous cell carcinoma.

An evaluation of insurance coverage indicates many patients in the US have limitations in access to care for lymphedema treatments.

Immersive virtual reality was associated with reduced anxiety and other outcomes for patients with cancer receiving chemotherapy.

Researchers sought to determine rates of infections for patients with multiple myeloma receiving autologous transplantation in India compared to other countries.

Adagrasib has shown durable clinical activity in patients with advanced KRAS^G12C-mutant NSCLC, according to updated results from the KRYSTAL-1 trial.

First-line treatment with serplulimab plus chemotherapy improves survival over chemotherapy alone in patients with advanced squamous NSCLC, a phase 3 trial suggests.